Clinical Trials Logo

Clinical Trial Summary

A prospective, randomized, controlled post-market clinical investigation that will enroll pediatric subjects requiring laceration repair. The investigation population will consist of 30 subjects fulfilling the eligibility criteria for the clinical investigation. The subjects will be randomly assigned at a 1:1 ratio to either the Zip 4 Surgical Skin Closure Device group or the Standard of Care sutures group.


Clinical Trial Description

The commercial use of the Zip device has demonstrated applicability and acceptance in many medical specialties, including laceration closure in the Emergency Department setting. However, while clinical studies have demonstrated quantitative performance benefits of the device in orthopedic, dermatology, cardiac and cardiology specialties, no quantitative studies have been conducted in the Emergency Department setting with the device with which emergency medicine physicians may make quantitative, informed treatment choices. The Sponsor (ZipLine Medical) and the study doctor (investigator) have furthermore identified the pediatric patient population presenting for laceration repair in the Emergency Department as a group that may uniquely benefit from the use of the Zip device.

Standard care for wounds of this type require cleaning the wound, anesthetizing the wound and closing the wound with sutures that typically require subsequent removal at a later date. The Zip device is non-invasive and therefore requires no injected anesthesia or sedation for wound closure. In addition, the referenced clinical studies have demonstrated at least a 3 times speed advantage over sutures. The Zip device ease of use and consistency of outcomes enables less skilled or experienced caregivers to perform fast, efficient and excellent wound closure, which can improve department and staff efficiency, patient throughput and overall patient satisfaction. Finally, the Zip device may be removed by the patient or parent at home, eliminating a return-to-clinic visit for removal.

ZipLine Medical believes that the demonstrated benefits of the Zip device will be more pronounced with the specified pediatric population due to reduced procedure time, elimination of injected anesthesia and elimination of a return visit for suture removal. ZipLine Medical believes that this will reduce fear and anxiety in pediatric patients. Furthermore, ZipLine Medical believes that the Zip device can improve Emergency Department efficiency and patient throughput, reduce overall healthcare cost and improve overall patient (and parent) satisfaction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04122859
Study type Interventional
Source ZipLine Medical Inc.
Contact Eric Storne
Phone 408.684.0747
Email estorne@ziplinemedical.com
Status Recruiting
Phase N/A
Start date November 1, 2018
Completion date July 31, 2020

See also
  Status Clinical Trial Phase
Terminated NCT03528512 - IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair Phase 4
Completed NCT06274073 - Double-dorsal Versus Single-volar Digital Block N/A
Recruiting NCT05934669 - IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED Phase 4
Completed NCT04091672 - RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction N/A
Completed NCT04617041 - Assessment of DAFILON® Suture Material for Skin Closure
Completed NCT04536493 - Comparison of 2 Application Techniques for LET Gel Used Prior to Simple Laceration Repair Phase 4
Recruiting NCT03628690 - A Post-Market Study of BandGrip in Traumatic Wound Closure Compared to Suture N/A
Recruiting NCT05383495 - Anxiolysis for Laceration Repair in Children Phase 3
Completed NCT03475901 - Virtual Reality for Anxiolysis During Laceration Repair in the Pediatric Emergency Room N/A